WHO target product profile for Nipah virus vaccines
14 June 2017
| Technical document
Overview
This document describes the preferred and minimally acceptable profiles for a human vaccine for reactive/emergency use intended to prevent Nipah virus (NiV) disease in vaccinated individuals as well as interrupt chains of transmission to terminate an outbreak.
WHO Team
R&D Blue Print (RDB)
Editors
World Health Organization
Number of pages
9